Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Arab Journal of Urology|February 28, 2022
The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic reviewMario Alvarez-Maestro, Francesco Chierigo, Guglielmo Mantica, et al.
Biotechniques|June 24, 2010
Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissuesIker Sánchez-Navarro, Angelo Gámez-Pozo, Manuel González-Barón, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 7, 2025
Fluorescence sensing mechanism of contaminant Cu<sup>2+</sup> in water by up-converting nanoparticlesRubén Puga, Gabriel López-Peña, Elisa Ortiz, et al.
Cancers|September 28, 2023
Predicting Risk of Severe Toxicity and Early Death in Older Adult Patients Treated with ChemotherapyJaime Feliu, Ana Belén Custodio, Alvaro Pinto-Marín, et al.
Clinical Genitourinary Cancer|June 27, 2025
Cabozantinib in the First-Line Treatment of Patients With Metastatic Renal Cell Carcinoma, Real-World Data From the Czech Republic and Poland: ICARO-RC ProjectJakub Kucharz, Alexandr Poprach, Bożena Sikora-Kupis, et al.
Plos One|June 24, 2009
Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancerEnrique Espinosa, Iker Sánchez-Navarro, Angelo Gámez-Pozo, et al.
Journal of the National Cancer Institute|November 1, 2017
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor StatusMatteo Lambertini, Niels Kroman, Lieveke Ameye, et al.
BMC Cancer|June 30, 2010
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancerIker Sánchez-Navarro, Angelo Gámez-Pozo, Alvaro Pinto, et al.
BMC Cancer|August 7, 2019
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)Javier Puente, Aranzazu González-Del-Alba, Núria Sala-Gonzalez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 4, 2024
Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in SpainJavier Puente, Alvaro Pinto, Maria José Mendez-Vidal, et al.
Pageof 6